论文部分内容阅读
试用延边地区流行性出血热病毒JR_2,JR_3株免疫猪制备的特异性转移因子(ITF)治疗流行性出血热(EHF),将84例早期典型EHT病人随机分为两组进行对照治疗。在41例ITF组中越过少尿期的有19例(46.34％),一般治疗(未用联合抗过敏疗法)组43例中有9例(20.93％)越过少尿期,两组有显著差异(P<0.05);尿蛋白复常天数ITF组为4.76,一般治疗组8.37,P<0.01;白细胞计数复常天数ITF组4.74,一般治疗组6.71,P<0.05;血小板计数复常天数ITF组4.82,一般治疗组8.42,P<0.01。本疗法对EHT早期病人在越期、减轻病情、缩短病程等方面均优于常规治疗组。
To test the epidemic hemorrhagic fever (EHF) by using the specific transfer factor (ITF) prepared from immunized pigs of epidemic hemorrhagic fever virus JR_2 and JR_3 in Yanbian area, 84 cases of early typical EHT patients were randomly divided into two groups for control treatment. There were 19 (46.34%) cases of oliguria in 41 cases of ITF group, 9 cases (20.93%) of the 43 cases in general treatment group (without combined anti-allergy therapy) crossed the oliguria period, and there was significant difference between the two groups (P <0.05). The number of days of urinary protein abnormality was 4.76 in ITF group and 8.37 in general treatment group (P <0.01). The number of leukocyte count days was 4.74 in ITF group and 6.71 in general treatment group (P <0.05) 4.82, the general treatment group 8.42, P <0.01. The treatment of EHT early patients in the more, reduce the disease, shorten the course of the disease are better than the conventional treatment group.